Rikke Bjerring Skyggebjerg is an author at Novo Nordisk (Denmark) specializing in diabetes, membrane transport, and extracellular matrix.
Top concepts
DiabetesMedicineBiochemistryMembrane TransportExtracellular MatrixMolecular PhysiologyBiomolecular Engineering
Publications per year
2015–2024
6
6
Development of Cagrilintide, a Long-Acting Amylin Analogue
Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl et al. · Journal of Medicinal Chemistry · 2021 · 107 citations
Rows per page
1–5 of 6